JD Health FY2025 operating income CNY3.8 billion up 158.5%

Reuters
Mar 05
<a href="https://laohu8.com/S/JD">JD</a> Health FY2025 operating income CNY3.8 billion up 158.5%

JD Health reported FY 2025 revenue of RMB73.4 billion (+26.3%), with gross profit of RMB18.2 billion (+36.7%) and operating income of RMB3.8 billion (+158.5%). Profit before income tax was RMB6.0 billion (+25.7%) and profit for the year was RMB5.4 billion (+29.1%). Non-IFRS operating income rose to RMB4.4 billion (+68.9%) and non-IFRS profit increased to RMB6.5 billion (+36.3%), with a non-IFRS profit margin of 8.9%. Basic earnings per share were RMB1.70 (diluted: RMB1.68). The company reported cash resources of RMB69.5 billion as of Dec. 31, 2025, and net cash generated from operating activities of RMB10.2 billion in FY 2025; it also reported no outstanding borrowings as of year-end. Operationally, JD Health said annual active users reached 217.7 million in the 12 months ended Dec. 31, 2025. It introduced over 100 new drugs during 2025, expanded online medical insurance payment services to 29 key cities, and ended 2025 with more than 300 self-operated pharmacies. The company highlighted AI healthcare initiatives including the AI agent “Dr. Da Wei,” which it said has completed hundreds of millions of patient interactions with a 98% user satisfaction rate, and noted deployment of its “JOY DOC” hospital solution at multiple hospitals, cumulatively serving over five million patients. JD Health also reported its at-home rapid testing service expanded to 27 cities, with FY 2025 order volume up 81.9%. The board did not recommend a final dividend for FY 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JD Health International Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260305-12041847), on March 05, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10